The Pennant Group, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from The Pennant Group, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 30% of its market value (net debt). Lower than 88% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 9.7 times by its yearly operating cash. Higher than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$184Over the last 3 years, every $100 of reported profit came with $184 of operating cash.
Higher than 70% of Healthcare companies in United States.
Self-Funding Ratio
4.1×Over the last 3 years its own operating cash covered its investment spending (capex) 4.1 times.
Higher than 83% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$5Sales grew 100% in 3 years; of every extra $100 of sales, $5 became extra profit.
Lower than 62% of Healthcare companies in United States.
Asset Productivity Ratio
+100% / +89%In 3 years sales changed by +100% while total assets changed by +89%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
9.7×Debt due within a year is covered 9.7 times by its yearly operating cash.
Higher than 85% of Healthcare companies in United States.
Cash Cushion Ratio
−30%Debt, after subtracting cash, equals 30% of its market value (net debt).
Lower than 88% of Healthcare companies in United States.
Tangible Assets Ratio
55%Of every $100 the company owns, $55 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 74% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 82% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
The Pennant Group, Inc. owes $0.61 for every $1 it owns. Net profit rose 31% in the year to Dec 2025, and grew 65% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
46.4Investors pay $46.4 for every $1 of The Pennant Group, Inc.'s yearly profit, higher than 79% of Healthcare companies in United States.
P/B ratio
4.11The share price is 4.11 times The Pennant Group, Inc.'s book value per share, higher than 66% of Healthcare companies in United States.
Market cap
$1.5 BThe total market value of all of The Pennant Group, Inc.'s shares at today's price (share price × number of shares), larger than 69% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$359 MWhat The Pennant Group, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$10.28Net worth divided by the number of shares. The share price of $42.23 is 4.1 times this, which is the P/B above.
Return on equity (ROE)
10.4%The Pennant Group, Inc. earned 10.4% on its shareholders' money over the last year, higher than 84% of Healthcare companies in United States.
Owes vs Owns
0.61×The Pennant Group, Inc. owes $0.61 for every $1 it owns (moderate), higher than 65% of Healthcare companies in United States.
Dividend yield
NoneThe Pennant Group, Inc. does not currently pay a dividend.
Revenue growth
+36%Revenue rose 36% in the year to Dec 2025, and grew 26% a year on average over 3 years.
Profit growth
+31%Net profit rose 31% in the year to Dec 2025, and grew 65% a year on average over 3 years.
Profit margin
3.1%The Pennant Group, Inc. keeps $3 of every $100 of revenue as net profit.
Cash quality
1.6×Cash from The Pennant Group, Inc.'s business was 1.6× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
7.6×The Pennant Group, Inc.'s operating profit covered its interest costs 7.6 times in the year to Dec 2025.
Cash vs debt
Net debtThe Pennant Group, Inc. had $436 M more debt than cash (net debt) at Dec 2025.
Questions
What is The Pennant Group, Inc.'s P/E ratio?
Investors pay $46.4 for every $1 of The Pennant Group, Inc.'s yearly profit, higher than 79% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For The Pennant Group, Inc.: $1.5 B ÷ $359 M (30 Jun 2026) = 4.1.
What is The Pennant Group, Inc.'s return on equity?
The Pennant Group, Inc. earned 10.4% on its shareholders' money over the last year, higher than 84% of Healthcare companies in United States.
How much does The Pennant Group, Inc. owe compared with what it owns?
The Pennant Group, Inc. owes $0.61 for every $1 it owns (moderate), higher than 65% of Healthcare companies in United States.
Does The Pennant Group, Inc. pay a dividend?
No. The Pennant Group, Inc. does not currently pay a dividend.
Is The Pennant Group, Inc.'s revenue growing?
Revenue rose 36% in the year to Dec 2025, and grew 26% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.